Patent ID: 7541359

Claim:
A compound of Formula (I): wherein: Ar 1 is a pyridyl, pyrimidinyl, thiazolyl, oxazolyl, naphthyl, or phenyl group, unsubstituted or substituted at a carbon ring member with one or two R a moieties; where each R a moiety is independently selected from the group consisting of —C 1-4 alkyl, —C 3-7 cycloalkyl, phenyl, benzyloxy, —C 2-4 alkenyl, —NO 2 , —CN, —OH, —OC 1-4 alkyl, fluoro, chloro, bromo, iodo, —CF 3 , —SH, —SC 1-4 alkyl, —SO 2 C 1-4 alkyl, —SOC 1-4 alkyl, —CO 2 C 1-4 alkyl, —CO 2 H, —COC 1-4 alkyl, —SO 2 NR b R c , —NR b SO 2 R c , —C(═O)NR b R c , —NR b C(═O)R c , and —N(R b )R c , where R b and R c are each independently —H or —C 1-4 alkyl, or R b and R c are taken together to form a 4- to 7-membered heterocycloalkyl ring; and R 2 is R 3 , R 4 , or Ar 2 , where R 3 is a —N-piperidinyl, —N-piperazinyl, —N-morpholinyl, —N-thiomorpholinyl, —N-dioxo-1λ 6 -thiomorpholinyl, or —N-pyrrolidinyl group, unsubstituted or substituted with one or two R d moieties; where each R d moiety is independently selected from the group consisting of —C 1-4 alkyl, —C 3-7 cycloalkyl, phenyl, —OH, and —C 2-4 alkenyl; R 4 is —NR e R f , wherein R e and R f are each independently —H, —C 1-4 alkyl, or —C 3-7 cycloalkyl; and Ar 2 is a phenyl, thiophenyl, furanyl, pyridyl, pyrimidinyl, or pyrazinyl group, unsubstituted or substituted at a carbon ring member with one or two R g moieties; where each R g moiety is independently selected from the group consisting of —C 1-4 alkyl, —C 3-7 cycloalkyl, phenyl, —C 2-4 alkenyl, —NO 2 , —CN, —OC 1-4 alkyl, fluoro, chloro, bromo, iodo, —CF 3 , —OCF 3 , —SCF 3 , —SC 1-4 alkyl, —SO 2 C 1-4 alkyl, —SOC 1-4 alkyl, —CO 2 C 1-4 alkyl, —COC 1-4 alkyl, —SO 2 NR h R i , —NR h SO 2 R i , —C(═O)NR h R i , —NR b C(═O)R c , and —N(R h )R i , where R h and R i are each independently —H or —C 1-4 alkyl or R b and R c are taken together to form a 4- to 7-membered heterocycloalkyl ring; and further wherein Ar 1 and R 2 are not both unsubstituted phenyl; or a pharmaceutically acceptable salt or pharmaceutically acceptable prodrug of such compound.